[1] [1] BOCKAERT J, PIN J P. Molecular tinkering of G protein-coupled receptors: an evolutionary success［J］. EMBO Journal, 1999, 18(7): 1723-1729.

[2] [2] BJARNADóTTIR T K, GLORIAM D E, HELLSTRAND S H, et al. Comprehensive repertoire and phylogenetic analysis of the G protein-coupled receptors in human and mouse［J］. Genomics, 2006, 88(3): 263-273.

[3] [3] PIERCE K L, PREMONT R T, LEFKOWITZ R J. Seven-transmembrane receptors［J］. Nature Reviews Molecular Cell Biology, 2002, 3(9): 639-650.

[4] [4] FREDRIKSSON R, LAGERSTR?M M C, H?GLUND P J, et al. Novel human G protein-coupled receptors with long N-terminals containing GPS domains and Ser/Thr-rich regions［J］. FEBS Letters, 2002, 531(3): 407-414.

[5] [5] HAMANN J, AUST G, ARA? D, et al. International union of basic and clinical pharmacology. XCIV. adhesion G protein-coupled receptors［J］. Pharmacological Reviews, 2015, 67(2): 338-367.

[6] [6] FREDRIKSSON R, LAGERSTR?M M C, LUNDIN L G, et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints［J］. Molecular Pharmacology, 2003, 63(6): 1256-1272.

[7] [7] LEJA J, ESSAGHIR A, ESSAND M, et al. Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas［J］. Modern Pathology, 2009, 22(2): 261-272.

[8] [8] TAKAHASHI N, DAWID I B. Characterization of zebrafish Rad52 and replication protein A for oligonucleotide-mediated mutagenesis［J］. Nucleic Acids Research, 2005, 33(13): e120.

[9] [9] VARSHNEY G K, ZHANG S, PEI W, et al. CRISPRz: a database of zebrafish validated sgRNAs［J］. Nucleic Acids Research, 2016, 44(D1): D822-826.

[10] [10] HARTY B L, KRISHNAN A, SANCHEZ N E, et al. Defining the gene repertoire and spatiotemporal expression profiles of adhesion G protein-coupled receptors in zebrafish［J］. BMC Genomics, 2015, 16(1): 62.

[11] [11] SUBTELNY A O, EICHHORN S W, CHEN G R, et al. Poly(A)-tail profiling reveals an embryonic switch in translational control［J］. Nature, 2014, 508(7494): 66-71.

[13] [13] ZHAN T, RINDTORFF N, BETGE J, et al. CRISPR/Cas9 for cancer research and therapy［J］. Seminars in Cancer Biology, 2019, 55: 106-119.

[14] [14] TYAGI S, KUMAR R, DAS A, et al. CRISPR-Cas9 system: a genome-editing tool with endless possibilities［J］. Journal of Biotechnology, 2020, 319: 36-53.

[15] [15] HSU P D, LANDER E S, ZHANG F. Development and applications of CRISPR-Cas9 for genome engineering［J］. Cell, 2014, 157(6): 1262-1278.

[16] [16] SANDER J D, JOUNG J K. CRISPR-Cas systems for editing, regulating and targeting genomes［J］. Nature Biotechnology, 2014, 32(4): 347-355.

[17] [17] HOSHIJIMA K, JURYNEC M J, KLATT SHAW D, et al. Highly efficient CRISPR-Cas9-based methods for generating deletion mutations and F0 embryos that lack gene function in zebrafish［J］. Developmental Cell, 2019, 51(5): 645-657.e644.

[18] [18] LEE H J, KIM E, KIM J S. Targeted chromosomal deletions in human cells using zinc finger nucleases［J］. Genome Research, 2010, 20(1): 81-89.

[19] [19] XIAO A, WANG Z, HU Y, et al. Chromosomal deletions and inversions mediated by TALENs and CRISPR/Cas in zebrafish［J］. Nucleic Acids Research, 2013, 41(14): e141.

[20] [20] GU Z, STEINMETZ L M, GU X, et al. Role of duplicate genes in genetic robustness against null mutations［J］. Nature, 2003, 421(6918): 63-66.

[21] [21] STAMBOULIAN M, GUERRERO R F, HAHN M W, et al. The ortholog conjecture revisited: the value of orthologs and paralogs in function prediction［J］. Bioinformatics, 2020, 36(Suppl_1): i219-i226.

[22] [22] KOONIN E V. Orthologs, paralogs, and evolutionary genomics［J］. Annual Review of Genetics, 2005, 39: 309-338.

[23] [23] DISS G, ASCENCIO D, DELUNA A, et al. Molecular mechanisms of paralogous compensation and the robustness of cellular networks［J］. Journal of Experimental Zoology Part B Molecular and Developmental Evolution, 2014, 322(7): 488-499.

[24] [24] LUZURIAGA-NEIRA A, SUBRAMANIAN K, ALVAREZ-PONCE D. Functional compensation of mouse duplicates by their paralogs expressed in the same tissues［J］. Genome Biology and Evolution, 2022, 14(8): evac126.

[25] [25] MA Z, ZHU P, SHI H, et al. PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components［J］. Nature, 2019, 568(7751): 259-263.

[26] [26] ROSSI A, KONTARAKIS Z, GERRI C, et al. Genetic compensation induced by deleterious mutations but not gene knockdowns［J］. Nature, 2015, 524(7564): 230-233.

[27] [27] KOK F O, SHIN M, NI C W, et al. Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish［J］. Developmental Cell, 2015, 32(1): 97-108.

[28] [28] EL-BROLOSY M A, STAINIER D Y R. Genetic compensation: a phenomenon in search of mechanisms［J］. PLoS Genetics, 2017, 13(7): e1006780.

[29] [29] EL-BROLOSY M A, KONTARAKIS Z, ROSSI A, et al. Genetic compensation triggered by mutant mRNA degradation［J］. Nature, 2019, 568(7751): 193-197.